0000925421-17-000343.txt : 20170925
0000925421-17-000343.hdr.sgml : 20170925
20170925164205
ACCESSION NUMBER: 0000925421-17-000343
CONFORMED SUBMISSION TYPE: 3/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170919
FILED AS OF DATE: 20170925
DATE AS OF CHANGE: 20170925
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Krishnan Krish S
CENTRAL INDEX KEY: 0001298709
FILING VALUES:
FORM TYPE: 3/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38210
FILM NUMBER: 171100182
MAIL ADDRESS:
STREET 1: 1881 GROVE AVENUE
CITY: RADFORD
STATE: VA
ZIP: 24141
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Krystal Biotech, Inc.
CENTRAL INDEX KEY: 0001711279
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 810930882
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2100 WHARTON STREET
STREET 2: SUITE 701
CITY: PITTSBURGH
STATE: PA
ZIP: 15203
BUSINESS PHONE: (412) 586-5830
MAIL ADDRESS:
STREET 1: 2100 WHARTON STREET
STREET 2: SUITE 701
CITY: PITTSBURGH
STATE: PA
ZIP: 15203
3/A
1
edgar.xml
PRIMARY DOCUMENT
X0206
3/A
2017-09-19
2017-09-19
0
0001711279
Krystal Biotech, Inc.
KRYS
0001298709
Krishnan Krish S
C/O KRYSTAL BIOTECH, INC.
2100 WHARTON STREET, SUITE 701
PITTSBURGH
PA
15203
1
1
1
0
President and CEO
Series A Convertible Preferred Stock
Common Stock
112162
I
By trust
The Series A convertible preferred stock will automatically convert on a one-to-one basis into 112,162 shares of common stock upon the closing of Krystal Biotech, Inc.'s initial public offering.
These shares were incorrectly included in the Non-Derivative Securities table in the reporting person's original Form 3, filed September 19, 2017.
The Krishnan Family Trust beneficially owns 112,162 shares of Series A convertible preferred stock. The reporting person and his spouse are each joint beneficial owners of the trust with joint voting and investment control.
/s/ Katherine A. Shaia,as attorney-in-fact for Krish S. Krishnan
2017-09-25